VSTM Q1 2025 Earnings — Verastem, Inc. Revenue & Financial Results | Market Cap Arena

VSTMVerastem, Inc.

$388M

Q1 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$44M

Net Income

-$52M

EPS (Diluted)

$-0.96

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$39M

Free Cash Flow

-$39M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$132M

Total Liabilities

$164M

Stockholders' Equity

-$32M

Cash & Equivalents

$118M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$44M	-$28M	-57.4%
Net Income	-$52M	-$34M	-53.9%